BeStock  
Stocks › Biotechnology › RLAY

Relay Therapeutics RLAY

US equityMarket cap rank #2302Biotechnology
$16.12 +$0.21 (+1.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $16.19 +0.46%
Open$15.59
Prev close$15.91
Day range$15.17 – $16.33
Volume3.98M
Market cap$3.56B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±4.5%last 16 reports
Closed higher5 of 1631% of the time
Best reaction+12.0%
Worst reaction-13.3%

Stock move on the day after each report

-5.4%2023/Q4-0.6%2024/Q1-7.9%2024/Q2-1.8%2024/Q3-13.3%2024/Q4-5.1%2025/Q1-7.7%2025/Q2-7.4%2025/Q3+12.0%2025/Q4-0.6%2026/Q1+0.1%2026/Q2-5.7%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q34 Nov 2026After Market±18.4%-5.71%Within range
2026/Q26 Aug 2026After Market±18.1%+0.10%Within range
2026/Q15 May 2026After Market±16.7%-0.62%Within range
2025/Q426 Feb 2026After Market–+12.01%–
2025/Q36 Nov 2025After Market±34.1%-7.35%Within range
2025/Q27 Aug 2025After Market±30.1%-7.74%Within range
2025/Q15 May 2025After Market±28.3%-5.12%Within range
2024/Q426 Feb 2025After Market±61.3%-13.33%Within range
2024/Q36 Nov 2024After Market±25.3%-1.76%Within range
2024/Q26 Aug 2024After Market±25.6%-7.93%Within range
2024/Q12 May 2024After Market±27.4%-0.57%Within range
2023/Q422 Feb 2024After Market±22.2%-5.39%Within range
2023/Q32 Nov 2023After Market±25.7%+1.62%Within range
2023/Q28 Aug 2023After Market±11.2%+0.09%Within range
2023/Q14 May 2023After Market±21.9%+0.45%Within range
2022/Q423 Feb 2023After Market±25.0%-2.12%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$90.25M-12.3% YoY
Net profit-$81.75M-10.2% YoY
Diluted EPS-$0.37+14.0% YoY
Free cash flow-$63.93M-2.9% YoY
Operating cash flow-$63.93M

Revenue, last 8 quarters

$0.0Dec '24$7.7MMar '25$677.0KJun '25$0.0Sep '25$7.0MDec '25$3.0MMar '26$350.0KJun '26$0.0Sep '26

Net profit, last 8 quarters

$-76.0MDec '24$-77.1MMar '25$-70.4MJun '25$-74.1MSep '25$-54.9MDec '25$-73.3MMar '26$-83.7MJun '26$-81.7MSep '26

Profitability & balance sheet

Operating margin-3,094.6%
Net margin-2,837.0%
Return on equity-41.2%
Return on assets-37.4%
Return on invested capital-43.1%
Current ratio14.62
Liabilities / assets9.2%
Cash & investments$848.64M
Total debt$23.54M
Net cash (debt)$825.10M

Discussion

No comments yet — be the first to weigh in on RLAY.

Sign in to join the discussion.

Scroll to Top